HO‐1 was also reported to function as a negative regulator in erastin‐ and sorafenib‐induced hepatocellular carcinoma ferroptosis as knockdown of HO‐1 enhanced cell growth inhibition by erastin and sorafenib. Here, HMOX1 is linked to hepatocellular carcinoma.